COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 513: Articles 5121-5130  | Next

DAPTEV: Deep aptamer evolutionary modelling for COVID-19 drug design
Andress, C., Kappel, K., Cuperlovic-Culf, M., Yan, H., Li, Y.
10.1101/2022.11.30.518473 — Posted: 2022-11-30
Proteomic profiling identifies biomarkers of COVID-19 severity
Harriott, N. C., Ryan, A. L.
10.1101/2022.11.29.518411 — Posted: 2022-11-30
Non-COVID-19 mortality in France, April 2020 - June 2022: reduction compared to pre-pandemic mortality patterns, relative increase during the Omicron period, and the importance of detecting SARS-CoV-2 infections
Goldstein, E.
10.1101/2022.11.28.22282832 — Posted: 2022-11-29
Trajectories of host-response biomarkers and inflammatory subphenotypes in COVID-19 patients across the spectrum of respiratory support.
Lu, M., Drohan, C., Bain, W., Shah, F. A., Bittner, M., Evankovich, J., Prendergast, N., Hensley, M., Suber, T., Fitzpatrick, M., Ramanan, R., Murray, H., Schaefer, C., Qin, S., Wang, X., Zhang, Y., Nouraie, S. M., Gentry, H., Kessinger, C., Patel, A., Macatangay, B. J., Jacobs, J., Mellors, J., Lee, J. S., Ray, P., Ray, A., Methe, B., Morris, A., McVerry, B. J., Kitsios, G. D.
10.1101/2022.11.28.22282858 — Posted: 2022-11-29
Atomic-level characterization of the conformational transition pathways in SARS-CoV-1 and SARS-CoV-2 spike proteins
Ogden, D. S., Moradi, M.
10.1101/2022.11.29.518406 — Posted: 2022-11-29
Disruption in seasonality, patient characteristics and disparities of respiratory syncytial virus infection among young children in the US during and before the COVID-19 pandemic: 2010-2022
Wang, L., Davis, p. B., Berger, N. A., Kaelber, D. C., Volkow, N., Xu, R.
10.1101/2022.11.29.22282887 — Posted: 2022-11-29
Persistent alveolar type 2 dysfunction and lung structural derangement in post-acute COVID-19
Rendeiro, A. F., Ravichandran, H., Kim, J., Borczuk, A., Elemento, O., Schwartz, R. E.
10.1101/2022.11.28.22282811 — Posted: 2022-11-29
Calpain-2 mediates SARS-CoV-2 entry and represents a therapeutic target
Zeng, Q., Antia, A., Chavez, M. P., Kutluay, S. B., Ding, S.
10.1101/2022.11.29.518418 — Posted: 2022-11-29
Virus-like particle displaying SARS-CoV-2 receptor binding domain elicits neutralizing antibodies and is protective in a challenge model
McKechnie, J. L., Fiala, B., Wolf, C., Ellis, D., Holtzman, D., Feldhaus, A.
10.1101/2022.11.29.518404 — Posted: 2022-11-29
Opinions of Former Jail Residents about Self-collection of SARS-CoV-2 Specimens, Paired with Wastewater Surveillance: A Qualitative Study Rapidly Examining Acceptability of COVID-19 Mitigation Measures
Montalvo, M. d. M., Dickson, P. F., Saber, L. B., Boehm, R., Phillips, V. L., Akiyama, M. J., Spaulding, A. C.
10.1101/2022.11.29.22282848 — Posted: 2022-11-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).